Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:cancer
gptkb:disease |
| gptkbp:affects |
gptkb:pleura
pericardium peritoneum mesothelial cells tunica vaginalis |
| gptkbp:causedBy |
asbestos exposure
|
| gptkbp:diagnosedBy |
gptkb:CT_scan
imaging MRI PET scan biopsy |
| gptkbp:field |
oncology
pathology pulmonology |
| gptkbp:firstDescribed |
1767
|
| gptkbp:hasEpidemiology |
rare
more common in men more common in older adults |
| https://www.w3.org/2000/01/rdf-schema#label |
Malignant mesothelioma
|
| gptkbp:ICD-10_code |
C45
|
| gptkbp:incidence |
~3,000 cases per year in US
|
| gptkbp:medianSurvival |
12-21 months
|
| gptkbp:mortalityRate |
high
|
| gptkbp:notableCase |
gptkb:Steve_McQueen
gptkb:Warren_Zevon |
| gptkbp:prevention |
avoid asbestos exposure
|
| gptkbp:prognosis |
poor
|
| gptkbp:riskFactor |
radiation exposure
asbestos erionite |
| gptkbp:subspecies |
biphasic mesothelioma
epithelioid mesothelioma sarcomatoid mesothelioma |
| gptkbp:symptom |
fatigue
weight loss shortness of breath chest pain pleural effusion |
| gptkbp:synonym |
mesothelioma
malignant pleural mesothelioma |
| gptkbp:treatment |
gptkb:cisplatin
gptkb:pemetrexed surgery radiation therapy chemotherapy immunotherapy |
| gptkbp:bfsParent |
gptkb:Mesothelioma
|
| gptkbp:bfsLayer |
7
|